ArticleJournal of visualized experiments : JoVE2026
Quantifying Embryonic Lethality Rate in Caenorhabditis elegans.
Article in Journal of visualized experiments : JoVE, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Embryonic lethality is a cornerstone phenotype used in Caenorhabditis elegans research to characterize developmental defects arising from factors such as toxic exposures and genetic mutations. Therefore, accurately quantifying the penetrance of embryonic lethality is critical for understanding the mechanisms and impact of these perturbations on animal development. Although automated scoring platforms exist, these approaches often require substantial financial investment and specialized hardware or software. This article describes a low-tech, low-cost assay that quantifies embryonic lethality by measuring the percentage of embryos that successfully fail to hatch. Notably, this version of the assay eliminates the need for a worm pick, making it exceptionally suitable for beginners. An additional advantage of this approach is that each technical replicate assays progeny from multiple animals, avoiding the potential biases of single-worm assays. This protocol includes a discussion of critical parameters, such as the minimum number of progeny required to accurately capture phenotype penetrance and the rationale for the methodology. Finally, we provide guidance on adapting the assay to assess the effects of gene knockdown via RNA interference, pharmacological treatments, or nutritional supplementation, adding a versatile and accessible tool to the toolkit of C. elegans researchers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.